Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 15357901)

1.

Influenza pandemics: can we prepare for the unpredictable?

Kilbourne ED.

Viral Immunol. 2004;17(3):350-7. Review.

PMID:
15357901
3.

Influenza vaccines: a main problem in control of pandemics.

Ghendon Y.

Eur J Epidemiol. 1994 Aug;10(4):485-6.

PMID:
7843363
4.

Live attenuated vaccines for pandemic influenza.

Chen GL, Subbarao K.

Curr Top Microbiol Immunol. 2009;333:109-32. doi: 10.1007/978-3-540-92165-3_5. Review.

PMID:
19768402
5.

Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.

O'Neill E, Donis RO.

Curr Top Microbiol Immunol. 2009;333:83-108. doi: 10.1007/978-3-540-92165-3_4. Review.

PMID:
19768401
6.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

7.

[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].

Kiseleva IV, Grigor'eva EP, Naĭkhin AN, Ivanova VV, Larionova NV, Donina SA, Litvinova OM, Aleksandrova GI, Rudenko LG.

Vopr Virusol. 2003 Jul-Aug;48(4):26-9. Russian.

PMID:
12945203
8.

Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.

[No authors listed]

Wkly Epidemiol Rec. 2003 Nov 21;78(47):405-8. English, French. No abstract available.

PMID:
14677515
9.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.

Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.

PMID:
18336962
10.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
11.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

13.

Vaccines against pandemic influenza: what can be done before the next pandemic?

Huber VC, McCullers JA.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S113-7. doi: 10.1097/INF.0b013e318168b749.

PMID:
18820570
14.

Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.

Michaelis M, Doerr HW, Cinatl J Jr.

Med Microbiol Immunol. 2009 Aug;198(3):175-83. doi: 10.1007/s00430-009-0118-5. Epub 2009 Jun 20. Review.

PMID:
19543913
15.

[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].

Kiseleva IV, Isakova IN, Larionova NV, Oleĭnik ES, Rudenko LG.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Nov-Dec;(6):40-5. Russian.

PMID:
18283733
16.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
17.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216
18.

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

Keitel WA, Atmar RL.

Curr Opin Pharmacol. 2007 Oct;7(5):484-90. Epub 2007 Jul 17. Review.

PMID:
17644429
19.

Development and characterization of a live attenuated influenza B virus vaccine candidate.

Seo SU, Byun YH, Lee EY, Jung EJ, Jang YH, Kim HA, Ha SH, Lee KH, Seong BL.

Vaccine. 2008 Feb 13;26(7):874-81. doi: 10.1016/j.vaccine.2007.12.022. Epub 2008 Jan 7.

PMID:
18207290
20.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk